Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools
Rob Arbuckle, Louise Humphrey, Lucy Abraham, Lorraine Dennerstein, James A Simon, Sebastian Mirkin, Nicola Bonner, Steven Wamsley, Sophi Tatlock, Tara Symonds
MATURITAS | ELSEVIER IRELAND LTD | Published : 2014
OBJECTIVES: To understand the vaginal bleeding/spotting experiences of postmenopausal (PM) women taking estrogen plus progestin therapies (EPT) and develop measures to assess these symptoms and their impact on women's daily lives in four countries. DESIGN: (1) Concept elicitation interviews were conducted with PM women in the US (n=14), Italy (n=15), Mexico (n=15) and China (n=15) to explore vaginal bleeding/spotting symptoms associated with EPT. The Post-Menopausal Bleeding Questionnaire (PMBQ) was also debriefed to evaluate understanding and comprehensiveness. (2) Based on concept elicitation, a single item electronic daily diary was developed and the PMBQ modified to form a 12-item impact..View full abstract
This work was sponsored by Pfizer Ltd.